Figure 2.
Apnoea–hypopnoea index before vs. after 3 months of sacubritil–valsartan (SV). Change in apnoea–hypopnoea index before vs. after 3 months of SV in (A) Group 1 and (B) Group 2 patients without positive airway pressure treatment.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.